ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 712,72
1,02%
Dow Jones
43 153,13
-0,16%
DAX
20 863,26
1,11%
Brent Oil
80,605
0,11%
Bitcoin
102 272,68
2,26%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Scienture Holdings Inc (SCNX)

  7. Scienture Holdings Inc (SCNX) Actualités

SCNX

Scienture (SCNX)

Scienture Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SCNX
DateHeureSourceTitreSymboleSociété
14/01/202512h34Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SCNXScienture Holdings Inc
08/01/202522h53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SCNXScienture Holdings Inc
30/12/202422h05Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsNASDAQ:SCNXScienture Holdings Inc
20/12/202422h05Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsNASDAQ:SCNXScienture Holdings Inc
19/12/202422h27Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:SCNXScienture Holdings Inc
17/12/202414h05GlobeNewswire Inc.Scienture Holdings, Inc. Announces Participation in The Microcap Conference 2025NASDAQ:SCNXScienture Holdings Inc
10/12/202414h05GlobeNewswire Inc.Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (NASDAQ: SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through 2041NASDAQ:SCNXScienture Holdings Inc
04/12/202416h41Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SCNXScienture Holdings Inc
26/11/202422h05GlobeNewswire Inc.Scienture Holdings, Inc. Announces Private Placement of $3 Million of 10% Secured Convertible Debentures as Initial Tranche of $12 Million Offering and Entry into $50 Million Equity Line of Credit AgreementNASDAQ:SCNXScienture Holdings Inc
06/11/202414h06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SCNXScienture Holdings Inc
24/09/202414h01GlobeNewswire Inc.TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to “SCNX”NASDAQ:SCNXScienture Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:SCNX

Dernières Valeurs Consultées

LATK
NEARETH
NEAR Protocol
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés